Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioSouth is a specialized contract development and manufacturing organization (CDMO) based in Christchurch, New Zealand, focusing on precision fermentation and microbial scale-up. The company provides critical infrastructure for scaling biological processes from laboratory research to industrial volumes, addressing a significant global bottleneck in fermentation capacity. Their services encompass process optimization, pilot-scale production, and full-scale commercial manufacturing of recombinant proteins, enzymes, and high-value bio-ingredients. BioSouth serves a diverse range of sectors, including biopharmaceuticals, agritech, and food technology. By offering flexible manufacturing solutions and leveraging New Zealand's biological expertise, the company facilitates the rapid commercialization of innovative bio-manufactured products for both domestic and international partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioSouth.